BioMedPartners closes BioMedInvest III at CHF100m
BioMedPartners AG, based in Basel, Switzerland, has held the final closing of BioMedInvest III, the company’s third equity venture capital fund, at CHF100 million. BioMedInvest III is a healthcare venture capital fund which invests in private early-to-mid- stage companies in Switzerland, Germany and neighbouring countries of the European Union.